Joanna Motyka

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Systematic Review

Platelet Rich Plasma

Top Venues

Medical science monitor : international medical journal of experimental and clinical research

Cancer management and research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Motyka, Aleksandra Kicman, Monika Kulesza, Sławomir Ławicki
CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients. Cancers 15 (12) (2023)
Joanna Motyka, Aleksandra Kicman, Monika Kulesza, Sławomir Ławicki
CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients. Cancers 15 (12) (2023)
Joanna Motyka, Ewa Gacuta, Aleksandra Kicman, Monika Kulesza, Paweł Malinowski, Sławomir Ławicki
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer. Cancer management and research 15 (2023)
Tomasz Guszczyn, Monika Kulesza, Aleksandra Kicman, Joanna Motyka, Sławomir Ławicki
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Paweł Ławicki, Paweł Malinowski, Joanna Motyka, Michał Ławicki, Aleksandra Kicman, Monika Kulesza, Ewa Gacuta, Tomasz Guszczyn, Marcin Januszkiewicz, Monika Zbucka-Krętowska, Sławomir Ławicki
Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients. Journal of clinical medicine 12 (7) (2023)
Tomasz Guszczyn, Monika Kulesza, Aleksandra Kicman, Joanna Motyka, Sławomir Ławicki
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Tomasz Guszczyn, Monika Kulesza, Aleksandra Kicman, Joanna Motyka, Sławomir Ławicki
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Tomasz Guszczyn, Monika Kulesza, Aleksandra Kicman, Joanna Motyka, Sławomir Ławicki
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Joanna Motyka, Ewa Gacuta, Aleksandra Kicman, Monika Kulesza, Paweł Ławicki, Sławomir Ławicki
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer. Journal of clinical medicine 11 (22) (2022)
Aleksandra Kicman, Marek Niczyporuk, Monika Kulesza, Joanna Motyka, Sławomir Ławicki
Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients. Cancer management and research 14 (2022)